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Background: Drugs dedicated to alleviate neurodegenerative diseases like Parkinson’s and Alzheimer’s have always
been associated with debilitating side effects. Medicinal mushrooms which harness neuropharmacological
compounds offer a potential possibility for protection against such diseases. Pleurotus giganteus (formerly known as
Panus giganteus) has been consumed by the indigenous people in Peninsular Malaysia for many years.
Domestication of this wild mushroom is gaining popularity but to our knowledge, medicinal properties reported for
this culinary mushroom are minimal.
Methods: The fruiting bodies P. giganteus were analysed for its nutritional values. Cytotoxicity of the
mushroom’s aqueous and ethanolic extracts towards PC12, a rat pheochromocytoma cell line was assessed by
using 3-[4,5-dimethythiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) assay. Neurite outgrowth stimulation assay
was carried out with nerve growth factor (NGF) as control. To elucidate signaling mechanisms involved by
mushroom extract-induced neurite outgrowth, treatment of specific inhibitor for MEK/ERK and PI3K signalling
pathway was carried out.
Results: The fruiting bodies of P. giganteus were found to have high carbohydrate, dietary fibre, potassium,
phenolic compounds and triterpenoids. Both aqueous and ethanolic extracts induced neurite outgrowth of PC12
cells in a dose- and time-dependant manner with no detectable cytotoxic effect. At day 3, 25 μg/ml of aqueous
extract and 15 μg/ml of ethanolic extract showed the highest percentage of neurite-bearing cells, i.e. 31.7 ± 1.1%
and 33.3 ± 0.9%; respectively. Inhibition treatment results suggested that MEK/ERK and PI3K/Akt are responsible for
neurite outgrowth of PC12 cells stimulated by P. giganteus extract. The high potassium content (1345.7 mg/100 g)
may be responsible for promoting neurite extension, too.
Conclusions: P. giganteus contains bioactive compounds that mimic NGF and are responsible for neurite
stimulation. Hence, this mushroom may be developed as a nutraceutical for the mitigation of
neurodegenerative diseases.
Keywords: Pleurotus giganteus, Medicinal mushroom, Edible mushroom, Neurite outgrowth,
Neurodegenerative disease, MEK/ERK signalling pathway, PI3K/Akt signalling pathway* Correspondence: viki@um.edu.my
1Mushroom Research Centre, Institute of Biological Sciences, Faculty of
Science, University of Malaya, 50603 Kuala Lumpur, Malaysia
2Institute of Biological Sciences, Faculty of Science, University of Malaya,
50603 Kuala Lumpur, Malaysia
Full list of author information is available at the end of the article
© 2012 Phan et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
Phan et al. BMC Complementary and Alternative Medicine 2012, 12:102 Page 2 of 11
http://www.biomedcentral.com/1472-6882/12/102Background
Neurodegenerative diseases are on the rise. The most
common form of neurodegenerative disease is Alzhei-
mer's disease, which causes thinking and memory to be-
come seriously impaired due to neuronal loss in brain
[1]. The second most common neurodegenerative syn-
drome, Parkinson's disease is characterised by the classic
symptoms of tremors, rigidity and gait impairment [2].
Medications to alleviate these neurodegenerative dis-
eases can only provide benefits for several years but are
not effective as the diseases progress [3]. Some un-
desired side effects associated with these drugs include
hallucinations, dyskinesia, nausea and constipation [2,3].
In this regard, complementary and alternative medicine
which is now gaining momentum may be a promising
way for prevention and protection against such neurode-
generative diseases [4].
Mushrooms are largely consumed not only in Asian
countries but across Western countries. Mushrooms are
of considerable interest because of their organoleptic
merit, medicinal properties and economic significance.
We have documented the effects of an edible mushroom
Hericium erinaceus (Bull.:Fr.) Pers. (also known as mon-
key’s head, lion’s mane, and yamabushitake) on neurite
outgrowth and peripheral nerve regeneration both
in vitro and in vivo [5-7]. More recently, the aqueous
extracts of Lignosus rhinoceros (Cooke) Ryvarden (tiger’s
milk mushroom) was reported to induce neurite out-
growth with or without the trigger of nerve growth fac-
tor (NGF) [8]. The cocktail of bioactive compounds
present in these mushroom extracts exhibits NGF-like
properties and play important roles in the growth, differ-
entiation and survival of neuronal cells [9-11].
Formerly known as Panus giganteus (Berk) Corner,
Pleurotus giganteus (Berk.) Karunarathna & K.D. Hyde is
a culinary mushroom that is gaining popularity for its
organoleptic properties and commercial prospects. In
fact, consumption of this used-to-be wild mushroom has
long been a tradition in the indigenous villages in Penin-
sular Malaysia [12]. A variety of P. giganteus from China
is now being cultivated in Malaysia and the common
commercial name in Malay language for P. giganteus is
“Seri Pagi” (morning glory). In China, P. giganteus is
widely referred as “Zhudugu” (swine’s stomach) [13]. It
is noteworthy to mention that the “Panus-Pleurotus-
Lentinus” complex has long existed and has resulted in
the confusion of nomenclature and taxonomy of these
three species. Briefly, Panus giganteus (Polyporaceae,
Polyporales) is characterised by its unbranched skeletal
hyphae that usually grow on buried woody substrates
[14]. While Pegler [15] has merged Panus as a subgenus
within Lentinus, Corner [14], has grouped the genus
Panus to species with skeletal hyphae and separated
those species with ligative hyphae in Lentinus. Hence,Lentinus giganteus is regarded as synonym for Panus
giganteus and Lentinus giganteus should be used if
recommendation of Pegler is ever adopted [13,16]. How-
ever, Karunarathna and colleagues have revisited this
issue and concluded that Panus/Lentinus giganteus
should be unified and positioned in Pleurotus as sup-
ported by molecular evidences [17].
Cell cultures derived from nervous system tissue have
proven to be powerful tools for elucidating cellular
mechanisms of nervous system function [18]. The effect
of chemicals, drugs, natural products or even growth
factors on neurite outgrowth can be quantified by enu-
merating the number of cells that bear neurites using
in vitro cell line model [19]. Neurite refers collectively to
“axons and dendrites extended by primary cells growing
in culture, or processes extended by neuronal cell lines,
which are neither definitive axons, nor dendrites”
[19,20]. Pheochromocytoma (PC12) cells, originated
from a rat adrenal medullary tumour (pheochromocy-
toma) have been widely employed as a model of neur-
onal differentiation and neurite outgrowth [21]. PC12
cells respond to NGF and when triggered, cease prolif-
eration, extend neurites, and become electrically excit-
able [22].
There is, however, minimal information on the medi-
cinal properties of P. giganteus. The aqueous and etha-
nolic extracts of P. giganteus have shown antioxidant,
genoprotection (unpublished data) and liver protection
properties [23]. To our knowledge, there are no reports
on the nutritional composition of P. giganteus and its
benefits on neurite outgrowth stimulation, if any. In
the present study, aqueous and ethanolic extracts of
P. giganteus fruiting bodies were investigated for their
effects in neurite outgrowth of rat pheochromocytoma
(PC12) cells. Prior to this, the cytotoxicity of the extracts
was determined by using [3-[4,5-dimethythiazol-2-yl]-
2,5-diphenyltetrazolium bromide] (MTT) assay. The hy-
pothesis that MEK/ERK and PI3K/Akt are required for
the neuronal differentiation and neurite outgrowth of
PC12 cells was also tested using specific inhibitors.
Methods
Materials and chemicals
The fruiting bodies of P. giganteus were obtained from
Nas Agro Farm, Sepang, Selangor, Malaysia. Rat pheo-
chromocytoma (PC-12) cell line was purchased from
American Type Culture Collection (ATCC; Rockville,
MD, USA; Catalogue Number: CRL-1721.1TM). [3-[4,5-
dimethythiazol-2-yl]-2,5-diphenyltetrazolium bromide]
(MTT), phosphate buffered saline (PBS), dimethyl sulf-
oxide (DMSO), F-12 K medium (Kaighn’s Modification
of Ham’s F-12 Medium), NGF-7 S from murine submax-
illary gland, MEK inhibitor (U0126, PD98059), and PI3K
inhibitor (LY294002) were obtained from Sigma Co. (St.
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serum (HS) were purchased from PAA Laboratories
(Cölbe, Germany).
Cultivation condition of mushrooms
Pleurotus giganteus (KUM61102) was maintained on po-
tato dextrose agar (PDA) at 4 - 10 °C and regularly sub-
cultured. The substrate formulation for the cultivation
of P. giganteus is similar to that for oyster mushroom
cultivation, i.e. 89 - 94% (w/w) rubber wood sawdust, 5 -
10% (w/w) rice bran and 1% (w/w) calcium carbonate.
Polypropylene bags are used for substrate bagging and
the moisture content in the substrate was kept at 60% -
65%. The temperature for mycelia growth, spawn run,
and fruiting body formation is 26 - 32 °C. Relative hu-
midity of 70% and 80 - 90% during mycelia growth and
fruiting; respectively, should be maintained. Direct illu-
mination should be avoided as it has been reported to
inhibit the fruiting body formation. A 20-day cycle after
complete colonization of the artificial log is needed for
each harvest and about four harvests (a total yield of
280 g) can be obtained from each bag of 900 g (Nas
Agro Farm, personal communication).
Cell culture
The PC12 cells (adherent variant, PC-12Adh) from
ATCC were maintained in F-12 K medium (Sigma) sup-
plemented with 2.5% (v/v) heat-inactivated fetal bovine
serum (PAA) and 15% (v/v) horse serum (PAA) with
final pH 6.8 - 7.2. All incubations were performed at
37 °C in a humidified environment of 5% CO2 and 95%
air. The cells were maintained in the logarithmic phase
of growth and were subcultured at 2–3 day intervals.
For storage, the cells were frozen at −70 °C liquid nitro-
gen in complete medium supplemented with 5% (v/v) di-
methyl sulfoxide (DMSO) (Sigma) as a cryoprotectant.
Extraction of P. giganteus fruiting bodies
The fresh fruiting bodies were sliced, weighed and
freeze-dried (Christ, Germany) for 1–2 days. The freeze-
dried fruiting bodies were then ground using a blender.
The resulting dried powder was weighed and kept in 4 -
8 °C. Aqueous extraction method was according to Eik
et al. [8]. Briefly, the freeze dried powder was soaked in
distilled water (1:20 ratio, w/v) and was left overnight at
room temperature and 200 rpm in a shaker. The mix-
ture was double boiled in water bath for 30 min and fil-
tered (Whatman Grade 4) after cooling. The resulting
aqueous extract was freeze-dried and kept at −40 °C
prior to use. For ethanol extraction, the freeze dried
powder was soaked in 95% ethanol at room temperature
for three days and the process was repeated three times.
The ethanol solvent was evaporated using a rotaryevaporator (Eyela N-1000, USA) to give a brownish vis-
cous extract.
Nutritional composition of freeze dried fruiting bodies
of P. giganteus
Fifty grams sample of P. giganteus fruiting bodies was
sent to Consolidated Laboratory (M) Sdn. Bhd. for nutri-
tional analysis.
Cell viability and cytotoxicity assay
Cell viability and proliferation was determined by MTT
assay [24]. Approximately 12,000 cells per well were
seeded on a 96-well plate and incubated at 37 °C over-
night in a humidified environment of 5% CO2 and 95%
air. Fresh medium were then replaced and the cells were
exposed to 0 to 1000 μg/ml of aqueous or ethanolic ex-
tract of P. giganteus for 48 hours. Subsequently, 20 μl of
sterilized MTT (5 mg/ml) in phosphate buffered saline
(PBS) buffer (pH 7.4) was spiked into each well and
incubated at 37 °C for 4 hours. The supernatant was
then carefully removed, and 200 μl of dimethyl sulfoxide
(DMSO) was added into each well to dissolve the MTT
formazan (blue colour) at the bottom of the wells. After
15 min, the absorbance at 540 nm with 690 nm as back-
ground absorbance was measured with an ELISA micro-
plate reader (Sunrise, Tecan, Austria). The complete
growth medium was the blank, and cells incubated in
medium only without mushroom extracts were denoted
as positive control.
Neurite outgrowth stimulation activity
Neurite outgrowth stimulation assay was according to
Eik et al. [8] with some modifications. The cells were
seeded in a 6-well plate at an initial density of 5,000 cells
per well in 2 ml complete growth medium with different
concentrations of aqueous and ethanolic mushroom
extracts. For freeze dried aqueous extract, a stock solu-
tion of 10 mg/ml was prepared freshly each time prior
to assay. The stock solution was then diluted five times
in sterile distilled water to final concentrations ranging
from 5–100 μg/ml (w/v). For ethanolic extract, 10 mg/
ml of stock solution in DMSO was prepared freshly. The
solution was also diluted five times with sterile distilled
water. In positive control experiments, cells were
induced to differentiate by the addition of 50 ng/ml (w/
v) NGF extracted from murine submaxillary gland
(Sigma). Cells in complete growth medium only served
as a negative control. All the cells were incubated for
five days at 37 °C, 95% air and 5% CO2 to observe any
neuronal differentiation activity.
Quantification of neurite bearing cells
A cell was scored positive if it bears a thin neurite exten-
sion that was double or more the length of the cell body
Table 1 The breakdown of nutritional content of
Pleurotus giganteus freeze-dried fruiting bodies
Test Parameter Result * Recommended daily
allowance (RDA)
Total Fat 3.7 65 g
• Saturated fat 0.97 -
• Monosaturated fat 1.97 -
• Polyunsaturated fat 0.77 -
• Trans fat N.D (<0.01 g/100 g) -
Energy in Kilo Calorie 364 kcal/100 g -
Protein 15.4 50 g
Cholesterol N.D (<0.001 mg/100 g) 300 mg
Carbohydrate 67.2 300 g
Dietary fibre 33.3 25 g
Sodium (as Na) 5.7 2400 mg
Calcium (as Ca) 5.78 1000 mg
Magnesium (as Mg) 67.64 0.4 g
Iron (as Fe) 1.85 18 mg
Zinc (as Zn) 2.68 15 mg
Phosphorus (as P) 526.45 700 mg
Potassium (as K) 1345.7 3500 mg
Copper (as Cu) 0.59 2.0 mg
Manganese (as Mn) 0.41 2.0 mg
Selenium (as Se) N.D (<0.02 mg/kg) 70 μg
* g or mg/100 g of freeze-dried fruiting bodies; test method was according to
AOAC (Association of Analytical Communities/Association of Official
Agricultural Chemist); ND: Not detectable.
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examined under an inverted microscope (Nikon Eclipse
TS100). The cells were photographed using a Nikon
DS-Fi1 camera and processed with a Nikon’s Imaging
Software, NIS-Elements D. The percentage of neurite-
bearing cells were quantified by scoring the number of
neurite-bearing cells over the total number of viable
cells in 10 microscopic fields with average of randomly
chosen 200 to 300 cells per well.
Treatment with specific inhibitors of signaling pathways
Stock solution (10 mM) of MEK inhibitor (U0126,
PD98059) and PI3K inhibitor (LY294002) were prepared
in DMSO and stored in −20 °C in the dark. Each inhibi-
tor i.e. 10 μM for U0126 [25], 10–50 μM of LY294002
[26]; and 40 μM for PD98059 [27] was then prepared by
diluting in medium just before use. PC12 cells were ei-
ther incubated with or without the treatment of inhibi-
tors for 1 hour. All the cells were then stimulated with
25 μg/ml of P. giganteus aqueous extract for three days
prior to scoring neurite bearing cells.
Statistical analysis
Results were expressed as the means ± standard devi-
ation (SD). Data comparison between groups was per-
formed using one-way analysis of variance (ANOVA).
P< 0.05 was considered to be significant between groups
by using Duncan's multiple range tests (DMRT).
Results
Nutritional composition of freeze dried fruiting bodies
of P. giganteus
The nutritional components of P. giganteus fruiting bod-
ies are shown in Table 1. Pleurotus giganteus contains
67.2 g/100 g of carbohydrate, 15.4 g/100 g of protein
and 33.3 g/100 g of dietary fibre. It is rich in minerals
like magnesium (67.64 mg/100 g) and potassium
(1345.7 mg/100 g).
The effects of aqueous and ethanolic extracts of
P. giganteus on PC12 cell viability
MTT assay was performed to determine the degree of
cytotoxicity of P. giganteus extracts in PC12 cell. The
cell viability and cell proliferation was denoted as 100%
for the positive control i.e. cells in complete growth
medium without mushroom extracts. It was shown that
the growth of PC12 cell decreased with the increasing
concentrations of the mushroom extracts. Figure 1a and
the negative region of Figure 1b and 1c indicates that
treatment with 10–200 μg/ml of aqueous extract and
10 μg/ml of ethanolic extract induced cell proliferation
significantly (p< 0.05) as compared to control after a
48 h incubation. Upon challenge with a threshold dosage
(500 μg/ml for aqueous extract and 200 μg/ml forethanolic extract), the number of viable cells decreased
significantly (p< 0.05) to 13.9% and 37.1%, respectively.
At a concentration of 1000 μg/ml, the different extracts
inhibited the cell proliferation to 75.65 ± 5.8% for aque-
ous extract, and 85.67 ± 5.3 for ethanolic extract. The
IC50 which is the concentration at which 50% of cell
growth inhibition occurs for aqueous extract and etha-
nolic extract were 806.39 ± 48 μg/ml and 309.46 ± 46 μg/
ml, respectively. Hence, ethanolic extract is more
toxic compared to aqueous extract, as the IC50 of etha-
nolic extract was 2.6-fold higher than that of aqueous
extract.
The effects of aqueous and ethanolic extracts of
P. giganteus on neurite outgrowth of PC12 cells
All concentrations of mushroom extracts tested were
non-cytotoxic to the cells, as determined by MTT assay.
Aqueous extract of P. giganteus induced neurite out-
growth of PC12 cells in both a time- and dose-
dependent manner (Figure 2a). On the second day,
the percentage of neurite-bearing cells increased signifi-
cantly (p< 0.05) to 18.8% after treatment with 25 μg/ml
of aqueous extract when compared to time-matched
negative control (9.5%). After stimulation with aqueous
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Figure 1 The effects of aqueous and ethanolic extracts of P. giganteus on PC12 cell viability. (a) Effect of aqueous extract and ethanolic
extract on the cell proliferation of PC12 cells. The mean absorbance obtained using medium with cells only was designated 100%. Results shown
represent the mean± SD; n= 3. *,¥ p< 0.05 for aqueous extract and ethanolic extract, respectively compared to the control 100%. (b) & (c): IC50
was obtained from the intercept on the x-axis (y = 0) of the regression line using the linear part of the percentage inhibition (% inh) curve (data
not shown).
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cantly increased (p< 0.05) until the effect reached a plat-
eau after day 3. Therefore, day 3 was selected for further
studies as the neurite scoring for all concentrations were
the highest. Similarly, ethanolic extract induced neurite
outgrowth of PC12 cells in a time- and dose-dependent
manner and the number of neurite-bearing cells
remained constant after day 3, as shown in Figure 2(b).
Figure 2c and 2d give the percentage of neurite-
bearing cells for aqueous extract and ethanolic extract,
respectively, on day 3. As shown in Figure 2c, aqueous
extract at 25 μg/ml had a significant (p< 0.05) effect
(31.7 ± 1.1%) in stimulating neuronal differentiation
compared to NGF (28.3 ± 0.4%). On day 3, 15 μg/ml ofethanolic extract induced 33.3 ± 0.9% of neurite-bearing
cells (Figure 2d). There was no significant difference
(p> 0.05) in the percentage of neurite-bearing cells
at 25 μg/ml of aqueous extract and 15 μg/ml of
ethanolic extract. However, both the extracts per-
formed better than NGF (p< 0.05). It was obvious
for ethanolic extract, that 50 μg/ml, 75 μg/ml and
100 μg/ml did not significantly (p> 0.05) trigger
neuronal differentiation and neurite outgrowth of
PC12 as compared to aqueous extract for the same
concentrations. Figure 3 shows the morphology of
PC12 cells with neurites at day-3 of treatment with
50 ng/ml NGF (a), 25 μg/ml of aqueous extract (b),
and neither of them (c).
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Figure 2 The effects of aqueous and ethanolic extracts of P. giganteus on neurite outgrowth of PC12 cells. (a) & (b) Time- and
dose-dependent neurite outgrowth induced by aqueous extract and ethanolic extract, respectively. * p< 0.05 compared with positive control
NGF and negative control. (c) & (d) Percentage of neurite-bearing cells on day 3 for aqueous extract and ethanolic extract, respectively. Results
shown represent the mean± SD; n= 5. Means not sharing a common letter were significantly different at p< 0.05.
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Figure 3 Phase-contrast photographs of PC12 neurites at day 3. (a) Treatment with 50 ng/ml NGF (b) Treatment with 25 μg/ml of aqueous
extract, and (c) Negative control, treatment of nither of (a) and (b). Scale bar = 20 μm. Arrows indicate neurite extentions.
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extracts of P. giganteus
It was shown that neurite outgrowth induced by NGF
and aqueous extract of P. giganteus was markedly inhib-
ited (p< 0.05) by MEK inhibitors U0126 and PD98059
(Figure 4a and 4b). In fact, in PC12 cell treated with
aqueous extract combined with either 10 μM of U0126
or 40 μM of PD98059, the decrease in the number of
neuritic processes was significant (p< 0.05). On the con-
trary, an inhibitor of PI3K/Akt pathway, LY294002, did
not inhibit aqueous extract- and NGF-induced neurite
outgrowth at the concentration of 10 μM and 20 μM
(p> 0.05). LY294002 at the concentration of 30 μM
started to cause inhibition effects on PC12 in a
concentration-dependent manner. At 30 μM of
LY294002, the number of elongated PC12 cells with neur-
ites doubled the cell diameter decreased significantly, by
49.6% and 63.5%, for NGF- and aqueous extract-treated
cells; respectively (Figure 4c). At 50 μM, all the cells pre-
treated with the inhibitor showed no difference (p> 0.05)
to the negative controls, with differentiated cells bearing
neurites ranging only from 3.2 – 5.3%. From this result,
we proposed that aqueous extract induced neurite out-
growth on PC12 cells via the activation of ERK1/2 cascade
and PI3K/AKt pathways.
Discussion
There is a vast amount of nutritional studies of wild and
cultivated mushrooms across the world. However, rela-
tively little data exist in the literature on the nutrient
content of Pleurotus giganteus. Herein, it was intended
to compare only the highly appreciated and most culti-
vated culinary-medicinal mushrooms, for example the
Pleurotus genus and Agaricus genus. Generally, mush-
rooms have high (19 – 35%) protein contents [28]. In
Brazil, it was reported that the fruiting bodies of Pleuro-
tus ostreatus and Pleurotus sajor-caju presented protein
content ranging from 13.1% to 18.4%, depending on the
substrates used [29]. The present study showed that theprotein level of P. giganteus is 5.3-time lower than that
of Agaricus bisporus (white button mushroom) with
reference to a study from Portugal [30]. On the other
hand, the carbohydrate content in P. giganteus is 4-, 6-,
7.2-, 7.5-, 8-, 11-time higher than that of Lentinula
edodes, shiitake (17.12 g/100 g), Flammulina velutipes,
golden needle mushroom (10.57 g/100 g), Pleurotus
ostreatus, oyster mushroom (9.30 g/100 g), Pleurotus
eryngii, king oyster mushroom (8.95 g/100 g), Agaricus
bisporus white button mushroom (8.25 g/100 g) (30),
and Agaricus bisporus brown mushroom (5.98 g/100 g)
[31]. This suggested that carbohydrates (glucose, manni-
tol, trehalose, oligosaccharide groups, and reserved poly-
saccharide like glycogen) account for the prevailing
component of P. giganteus fruiting body. Reports related
to the nutritional evaluation of Pleurotus genus carried
out by other researchers from different regions (Japan,
India, Bangladesh, Turkey, Finland, and Italy) can be
retrieved from [32–37], respectively. Nevertheless, the
differences between the nutrient values may be attribu-
ted to the type of mushroom, strain of mushroom, envir-
onmental factors, and composition of growth media
[37].
MTT assay is by far the most convenient colorimetric
assay based on the metabolic activity of a viable cell
[24,38]. Basically, only viable cell has the mitochondrial
dehydrogenase system that can cleave the yellow MTT
tetrazolium salt and yield MTT formazan which is blue
in colour. Thus, the optical density of the amount of
solubilised MTT formazan is quantitatively correlated to
the percentage of cell viability. The present study
showed that cytotoxic effect of P. giganteus aqueous and
ethanolic extracts towards PC12 cells were concentra-
tion dependant. This is consistent with the finding by
Cheung et al. [39] whereby viability of PC12 cells was
dose-dependently decreased by increasing Ganoderma
lucidum extracts.
On-going studies show that the aqueous extract of P.
giganteus contains bioactive secondary metabolites like
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control group.
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pounds are reported to have neutrophic NGF-like
properties and caused neurite outgrowth activity in
PC12 cells [40]. We have shown for the first time that
P. giganteus extract can stimulate neurite outgrowth
by using PC12 cell line model. It was shown that
25 μg/ml of aqueous extract and 15 μg/ml of ethanolic
extract induced the highest percentage of neurite out-
growth in PC12 cells at day 3. The number of neurite
bearing cells was significantly higher than that of NGF.
The mushroom extracts may contain bioactive com-
pounds either mimic NGF or trigger the production of
NGF, hence resulting in neurite outgrowth. Further, the
potassium level in P. giganteus was 1345.7 mg/100 g and
according to Kalac [41], potassium level in fruiting bodies
is between 20- and 40-fold higher than in the substrates
used for mushroom cultivation. In the study by Cohen-
Cory et al. [42], the cell number of Purkinje cells, the
major efferent neurons of the brain cerebellum increased
by 40% when treated with potassium. Besides, potassiumalone or potassium coupled with NGF markedly
increased the cell survival, cell differentiation and neurite
outgrowth. In this study, the potassium present in P.
giganteus extracts may be involved in the regulation of
the morphological differentiation of PC12 cells by acting
as a depolarising agent.
The present study extends recent findings that some
mushroom extracts can have neuritogenesis effects. Prior
studies by our group have shown that 0.2% (v/v) aqueous
extract of freeze dried fruiting bodies from Hericium eri-
naceus caused maximal stimulation of neurite outgrowth
(17.3% of neurite bearing cells and 88.2% increase com-
pared to control) in NG108-15 cell line after 24 hours of
incubation [5]. Besides, freeze drying was found to be
the best approach to preserve the bioactive compounds
in mushroom as compared to oven-dried method [43]. It
had been reported that PC12 cells responded well to
water extract of sclerotium of Lignosus rhinocerus
(Cooke) Ryvarden [8]. It was found that synergistic ef-
fect, i.e. 42.12% of neurite bearing PC12 cells was
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water extract combined with 30 ng/ml of NGF. Some
other medicinal mushrooms that induced neurite out-
growth included Grifola frondosa (Maitake) [10], Tricho-
loma sp [44], Termitomyces albuminosus [45,46],
Dictyophora indusiata [47], Tremella fuciformis [48], and
Ganoderma lucidium (Lingzhi) [39].
The involvement of the MAPK/ERKs signaling path-
way in neuronal differentiation by mushroom extracts
has been reported. Neuroprotective and neuritogenesis
effect of Ganoderma lucidium extracts on PC12 was sti-
pulated to be mediated via the MAPK/ERK signalling
pathway [39]. Besides, lysophosphatidylethanolamine
from Grifola frondosa induced activation of ERK1/2 of
PC12 cells thus stimulated neurite outgrowth and inhib-
ited serum withdrawal-induced apoptosis [10]. Neuro-
trophins like NGF are mostly mediated by the Trk
family of receptor tyrosine kinase, TrKA. However, dis-
crepancy did occur in the case of Ganoderma lucidium
extracts, whereby there was no direct involvement of
TrkA [39]. Similarly, α-Phenyl-N-tert-butylnitron was
also found to induce neurite outgrowth in PC12 inde-
pendent of TrkA [49]. It is thus predicted, based on the
ability of P. giganteus extract to stimulate neurite out-
growth of PC12 without NGF, that activation of TrKA
receptor tyrosine kinase may not be necessary. Accord-
ing to Sweatt [50], the mitogen-activated protein kinase
(MAP kinase, MAPK) cascade is a superfamily of signal-
ling cascade and is a vital regulator of cell division and
differentiation. Recently, MAPK was specified as the
extracellular signal-regulated kinase (ERK) comprising
ERK 1 and 2, or as ERK1/2. It has been demonstrated
that ERK-cascade was necessary and sufficient enough
for NGF-induced neuronal differentiation of PC12 cells.
In the present study, upon inhibition by MEK-selective
inhibitor U0126 and PD98059, the percentage of neurite
outgrowth decreased significantly. This suggested that
ERK1/2 phosphorylation was affected and this indirectly
implied that activation of ERK1/2 is necessary for P.
giganteus-mediated neuritogenesis. Inhibition of PI3K/
Akt signalling by LY294002 also negatively affected
neurite outgrowth of PC12. This finding suggested that
neurite outgrowth potentiated by P. giganteus in PC12
cells is also regulated by PI3K/Akt signaling pathway.
However, it was noted that PI3K/Akt inhibitor did not
markedly affect the activities of ERK [51], therefore
neurite extension of PC12 still could be observed at
lower concentrations of LY294002. According to Naidu
et al. [52], phospho-Akt and phospho-MAPK were
expressed during neurodevelopment and nerve regener-
ation following sciatic nerve crush on rats. Collectively,
these results demonstrated that P. giganteus-induced
neurite extension is regulated at least by part between
MEK/ERK and PI3K/Akt pathways. For the future work,confirmation by immunoblot analysis to detect the phos-
phorylation of TrKA, ERK, and Akt, is necessary.
Conclusions
To our knowledge, this is the first evidence on the
effects of Pleurotus giganteus aqueous and ethanol
extracts on neuronal differentiation and neurite out-
growth. The high potassium level in the fruiting bodies
and the presence of bioactive compounds (mainly triter-
penoids) could be responsible for the neuroactivity.
Work is in progress to determine and identity the bio-
active compound/s responsible for the activity. Our
results suggested that neurite outgrowth stimulated by
P. giganteus is mediated via the “cross-talk” between
MEK/ERKs and PI3K/Akt pathways. However, further
immunoblot analysis is required.
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